Biotech · Private company

Conjupro Biotherapeutics, Inc.

Track this companyFree. Adds Conjupro Biotherapeutics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials83 recruiting or active

Pipeline programs9From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline9

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid TumorsPHASE1 · RECRUITING · started Mar 3, 2026ClinicalTrials.gov NCT07424547 · fetched Nov 12, 2026
A Phase 1 Study of JMT108 in Participants With Advanced Solid TumorsPHASE1 · RECRUITING · started Dec 2, 2025ClinicalTrials.gov NCT07317505 · fetched Nov 12, 2026
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid TumorsPHASE1 · RECRUITING · started Jun 6, 2023ClinicalTrials.gov NCT05948865 · fetched Nov 12, 2026
Dose Escalation and Expansion Study of CPO107 for Patients With Advanced CD20-positive Non-Hodgkins LymphomaPHASE1 · TERMINATED · started Dec 13, 2021ClinicalTrials.gov NCT04853329 · fetched Nov 12, 2026
Single and Multiple Doses of HA115 and Food Effect in Healthy Adult VolunteersPHASE1 · WITHDRAWN · started Oct 1, 2021ClinicalTrials.gov NCT03567694 · fetched Nov 12, 2026
Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid TumorsPHASE1 · TERMINATED · started Mar 24, 2021ClinicalTrials.gov NCT04931823 · fetched Nov 12, 2026
PLM60 for Peripheral T Cell Lymphoma (PTCL)PHASE1_PHASE2 · WITHDRAWN · started Jan 1, 2021ClinicalTrials.gov NCT03553914 · fetched Nov 12, 2026
Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy SubjectsPHASE1 · COMPLETED · started May 31, 2018ClinicalTrials.gov NCT03657550 · fetched Nov 12, 2026